0
0
0
No Taxpayer Dollars for Communist China COVID Tests Act
1/25/2024, 8:45 PM
Summary of Bill S 3454
Bill 118 s 3454, also known as the No Taxpayer Dollars for Communist China COVID Tests Act, is a piece of legislation introduced in the US Congress. The main purpose of this bill is to prohibit the use of taxpayer funds for COVID-19 testing that is conducted in laboratories owned or operated by the Chinese government or the Chinese Communist Party.
The bill aims to prevent any taxpayer dollars from being used to support COVID-19 testing in China, as there are concerns about the accuracy and reliability of testing conducted in Chinese laboratories. Supporters of the bill argue that it is important to ensure that taxpayer funds are not inadvertently supporting the Chinese government or Communist Party, especially in light of ongoing tensions between the US and China.
Opponents of the bill argue that it could hinder efforts to combat the COVID-19 pandemic by limiting access to testing resources. They also raise concerns about the potential impact on diplomatic relations between the US and China. Overall, the No Taxpayer Dollars for Communist China COVID Tests Act is a controversial piece of legislation that raises important questions about the use of taxpayer funds and the relationship between the US and China. It will be interesting to see how this bill progresses through Congress and what impact it may have on COVID-19 testing efforts.
The bill aims to prevent any taxpayer dollars from being used to support COVID-19 testing in China, as there are concerns about the accuracy and reliability of testing conducted in Chinese laboratories. Supporters of the bill argue that it is important to ensure that taxpayer funds are not inadvertently supporting the Chinese government or Communist Party, especially in light of ongoing tensions between the US and China.
Opponents of the bill argue that it could hinder efforts to combat the COVID-19 pandemic by limiting access to testing resources. They also raise concerns about the potential impact on diplomatic relations between the US and China. Overall, the No Taxpayer Dollars for Communist China COVID Tests Act is a controversial piece of legislation that raises important questions about the use of taxpayer funds and the relationship between the US and China. It will be interesting to see how this bill progresses through Congress and what impact it may have on COVID-19 testing efforts.
Congressional Summary of S 3454
No Taxpayer Dollars for Communist China COVID Tests Act
This bill prohibits the use of federal funds to procure at-home COVID-19 tests that are imported from or manufactured (in whole or in part) in China or that are manufactured by any subsidiary of a Chinese company.
Read the Full Bill
Current Status of Bill S 3454
Bill S 3454 is currently in the status of Bill Introduced since December 7, 2023. Bill S 3454 was introduced during Congress 118 and was introduced to the Senate on December 7, 2023. Bill S 3454's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of December 7, 2023
Bipartisan Support of Bill S 3454
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
10Democrat Cosponsors
0Republican Cosponsors
10Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 3454
Primary Policy Focus
HealthAlternate Title(s) of Bill S 3454
No Taxpayer Dollars for Communist China COVID Tests Act
No Taxpayer Dollars for Communist China COVID Tests Act
A bill to prohibit the use of Federal funds to purchase at-home tests for SARS-CoV-2 from certain foreign entities.
Comments
Sponsors and Cosponsors of S 3454
Latest Bills
National Defense Authorization Act for Fiscal Year 2026
Bill S 1071December 15, 2025
Foundation of the Federal Bar Association Charter Amendments Act of 2025
Bill S 616December 15, 2025
Intelligence Authorization Act for Fiscal Year 2026
Bill HR 5167December 15, 2025
To expand the sharing of information with respect to suspected violations of intellectual property rights in trade.
Bill HR 4930December 15, 2025
Veteran Fraud Reimbursement Act of 2025
Bill HR 1912December 15, 2025
Montgomery GI Bill Selected Reserves Tuition Fairness Act of 2025
Bill HR 983December 15, 2025
Fairness for Servicemembers and their Families Act of 2025
Bill HR 970December 15, 2025
Miracle on Ice Congressional Gold Medal Act
Bill HR 452December 15, 2025
Improving Interagency Coordination for Pipeline Reviews Act
Bill HR 3668December 15, 2025
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Land Management relating to "Central Yukon Record of Decision and Approved Resource Management Plan".
Bill HJRES 106December 15, 2025
No Taxpayer Dollars for Communist China COVID Tests Act
Bill HR 6668February 5, 2024





